Skip to content


Top Articles for ADI 2017

Risk reduction and risk factors

New Content Item

Increased dementia risk predominantly in diabetes mellitus rather than in hypertension or hyperlipidemia: a population-based cohort study

Yen-Chun Fan, Jung-Lung Hsu, Hong-Yi Tung, Chia-Chi Chou and Chyi-Huey Bai

Published on: 6 February 2017

New Content Item​​​​​​​

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer’s disease

Nophar Geifman, Roberta Diaz Brinton, Richard E. Kennedy, Lon S. Schneider and Atul J. Butte

Published on: 17 February 2017

Early intervention

New Content Item

Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study​​​​​​​

Meera Sheffrin, Irena Stijacic Cenzer and Michael A. Steinman

Published on: 13 December 2016


New Content Item

SORL1 gene, plasma biomarkers, and the risk of Alzheimer’s disease for the Han Chinese population in Taiwan

Cheng-Ta Chou, Yi-Chu Liao, Wei-Ju Lee, Shuu-Jiun Wang and Jong-Ling Fuh

Published on: 30 December 2016

New Content Item​​​​​​​

Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review

S. A. S. A. Bemelmans, K. Tromp, E. M. Bunnik, R. J. Milne, S. Badger, C. Brayne, M. H. Schermer and E. Richard

Published on: 10 November 2016

Diagnosis and imaging

New Content Item

Unbiased estimates of cerebrospinal fluid β-amyloid 1–42 cutoffs in a large memory clinic population

Daniela Bertens, Betty M. Tijms, Philip Scheltens, Charlotte E. Teunissen and Pieter Jelle Visser

Published on: 14 February 2017

Retinal vascular and structural changes are associated with amyloid burden in the elderly: ophthalmic biomarkers of preclinical Alzheimer’s disease

S.Mojtaba Golzan, Kathryn Goozee, Dana Georgevsky, Alberto Avolio, Pratishtha Chatterjee, Kaikai Shen, Vivek Gupta, Roger Chung, Greg Savage, Carolyn F. Orr, Ralph N. Martins and Stuart L. Graham

Published on: 1 March 2017

New Content Item

A digital enzyme-linked immunosorbent assay for ultrasensitive measurement of amyloid-β 1–42 peptide in human plasma with utility for studies of Alzheimer’s disease therapeutics

Linan Song, D. Richard Lachno, David Hanlon, Adam Shepro, Andreas Jeromin, Dipika Gemani, Jayne A. Talbot, Margaret M. Racke, Jeffrey L. Dage and Robert A. Dean

Published on: 15 December 2016

Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer’s disease

Panagiotis Alexopoulos, Lukas Werle, Jennifer Roesler, Nathalie Thierjung, Lena Sophie Gleixner, Igor Yakushev, Nikolaos Laskaris, Stefan Wagenpfeil, Philippos Gourzis, Alexander Kurz and Robert Perneczky

Published on: 9 December 2016

Non-AD Dementias

New Content Item

A cognitive electrophysiological signature differentiates amnestic mild cognitive impairment from normal aging

Juan Li, Lucas S. Broster, Gregory A. Jicha, Nancy B. Munro, Frederick A. Schmitt, Erin Abner, Richard Kryscio, Charles D. Smith and Yang Jiang

Published on: 19 January 2017

New Content Item

An update on semantic dementia: genetics, imaging, and pathology

Ramon Landin-Romero, Rachel Tan, John R. Hodges and Fiona Kumfor

Published on: 5 December 2016

New Content Item

On our On Medicine blog, Marc Wortmann, Executive Director at Alzheimer's Disease International, outlines the World Health Organization's comprehensive Global Action Plan for tackling dementia, and explains why this plan is so important for the future of dementia care and research.

Read more of this post.

Read older blog posts for more insights on Alzheimer’s disease and dementia latest developments.

It's Quiz time!


How much do you know about Alzheimer’s? And about the architecture of your brain? Take our quizzes and test your knowledge.

Don't forget to tweet your scores!

World Alzheimer’s Day 2016 Quiz

Brain Awareness Week 2017 Quiz​​​​​​​

Publishing your research: what do Editors look for?

New Content Item (1)

Join our session on how to get published with Professor Scheltens, Editor-in-Chief of Alzheimer's Research & Therapy.

Date: Thursday 27th April

Time: 17:45-18:45 

Venue: Room A, 2nd Floor

Affiliated with